Aflibercept for ROP Shows Sustained Efficacy at Age 3
TOPLINE: A src.4 mg dose of aflibercept in infancy to treat retinopathy of prematurity (ROP) shows sustained efficacy and safety at...
TOPLINE: A src.4 mg dose of aflibercept in infancy to treat retinopathy of prematurity (ROP) shows sustained efficacy and safety at...